1. Home
  2. ANSC vs KRRO Comparison

ANSC vs KRRO Comparison

Compare ANSC & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANSC
  • KRRO
  • Stock Information
  • Founded
  • ANSC 2021
  • KRRO 2014
  • Country
  • ANSC United States
  • KRRO United States
  • Employees
  • ANSC N/A
  • KRRO N/A
  • Industry
  • ANSC
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANSC
  • KRRO Health Care
  • Exchange
  • ANSC Nasdaq
  • KRRO Nasdaq
  • Market Cap
  • ANSC 452.8M
  • KRRO 490.1M
  • IPO Year
  • ANSC 2023
  • KRRO 2019
  • Fundamental
  • Price
  • ANSC $10.51
  • KRRO $37.00
  • Analyst Decision
  • ANSC
  • KRRO Strong Buy
  • Analyst Count
  • ANSC 0
  • KRRO 7
  • Target Price
  • ANSC N/A
  • KRRO $133.83
  • AVG Volume (30 Days)
  • ANSC 51.9K
  • KRRO 102.8K
  • Earning Date
  • ANSC 01-01-0001
  • KRRO 11-12-2024
  • Dividend Yield
  • ANSC N/A
  • KRRO N/A
  • EPS Growth
  • ANSC N/A
  • KRRO N/A
  • EPS
  • ANSC 0.21
  • KRRO N/A
  • Revenue
  • ANSC N/A
  • KRRO N/A
  • Revenue This Year
  • ANSC N/A
  • KRRO N/A
  • Revenue Next Year
  • ANSC N/A
  • KRRO N/A
  • P/E Ratio
  • ANSC $50.30
  • KRRO N/A
  • Revenue Growth
  • ANSC N/A
  • KRRO N/A
  • 52 Week Low
  • ANSC $10.10
  • KRRO $30.01
  • 52 Week High
  • ANSC $10.51
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • ANSC 61.67
  • KRRO 39.89
  • Support Level
  • ANSC $10.49
  • KRRO $36.02
  • Resistance Level
  • ANSC $10.50
  • KRRO $39.04
  • Average True Range (ATR)
  • ANSC 0.01
  • KRRO 3.22
  • MACD
  • ANSC -0.00
  • KRRO 0.08
  • Stochastic Oscillator
  • ANSC 90.00
  • KRRO 34.24

About ANSC Agriculture & Natural Solutions Acquisition Corporation

Agriculture & Natural Solutions Acquisition Corp is a blank check company.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: